United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostini...(ied by the cautionary statements caution...)

Date:3/16/2009

ied by the cautionary statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and current reports on Form 8-K, which could cause actual results to differ materially from anticipated results. We are providing this information as of March 16, 2009, and assume no obligation to update or revise the information contained in this press release whether as a result of new information, future events or any other reason. [uthr-g]

'/>"/>

SOURCE United Therapeutics Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations
2. The Society of Forensic Toxicologists Comments on the National Academy of Sciences Report on Strengthening Forensic Science in the United States
3. Surgeons Perform First Incisionless Bariatric Procedure in the United States
4. CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States
5. United Therapeutics to Announce 2008 Fourth Quarter and Annual Financial Results Before Market Open on Tuesday, February 17, 2009
6. Organic, Preservative-Free Skin Care Products from Dermaheal Now Available in the United States
7. Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP)
8. Enigma Diagnostics Announces the Opening of a United States Office
9. First United Kingdom Patients Treated With Percutaneous MitraClip(R) System
10. Lilly Contributes $11.1 Million to United Way Annual Campaign
11. United Therapeutics Reports Third Quarter 2008 Financial Results